Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ARV-806 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on ARV-806, a putative KRAS G12D degrader (Jun 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ARV-806 | ARV806|ARV 806 | KRAS G12D Inhibitor 25 | Limited information is currently available on ARV-806, a putative KRAS G12D degrader (Jun 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07023731 | Phase Ib/II | ARV-806 | A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation | Recruiting | USA | 0 |